SI-BONE (SIBN) Competitors $19.12 -0.59 (-2.99%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$19.11 -0.01 (-0.07%) As of 08:29 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SIBN vs. PRCT, NVST, LIVN, ENOV, NVCR, LMAT, SSII, CNMD, WRBY, and EYEShould you be buying SI-BONE stock or one of its competitors? The main competitors of SI-BONE include PROCEPT BioRobotics (PRCT), Envista (NVST), LivaNova (LIVN), Enovis (ENOV), NovoCure (NVCR), LeMaitre Vascular (LMAT), SS Innovations International (SSII), CONMED (CNMD), Warby Parker (WRBY), and National Vision (EYE). These companies are all part of the "medical equipment" industry. SI-BONE vs. PROCEPT BioRobotics Envista LivaNova Enovis NovoCure LeMaitre Vascular SS Innovations International CONMED Warby Parker National Vision PROCEPT BioRobotics (NASDAQ:PRCT) and SI-BONE (NASDAQ:SIBN) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, community ranking, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk. Do analysts recommend PRCT or SIBN? PROCEPT BioRobotics currently has a consensus target price of $90.00, indicating a potential upside of 58.90%. SI-BONE has a consensus target price of $22.50, indicating a potential upside of 17.68%. Given PROCEPT BioRobotics' higher probable upside, research analysts clearly believe PROCEPT BioRobotics is more favorable than SI-BONE.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PROCEPT BioRobotics 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86SI-BONE 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community favor PRCT or SIBN? SI-BONE received 133 more outperform votes than PROCEPT BioRobotics when rated by MarketBeat users. However, 70.00% of users gave PROCEPT BioRobotics an outperform vote while only 69.17% of users gave SI-BONE an outperform vote. CompanyUnderperformOutperformPROCEPT BioRoboticsOutperform Votes4270.00% Underperform Votes1830.00% SI-BONEOutperform Votes17569.17% Underperform Votes7830.83% Does the media prefer PRCT or SIBN? In the previous week, SI-BONE had 6 more articles in the media than PROCEPT BioRobotics. MarketBeat recorded 14 mentions for SI-BONE and 8 mentions for PROCEPT BioRobotics. PROCEPT BioRobotics' average media sentiment score of 1.57 beat SI-BONE's score of 0.42 indicating that PROCEPT BioRobotics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PROCEPT BioRobotics 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SI-BONE 7 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility and risk, PRCT or SIBN? PROCEPT BioRobotics has a beta of 1.1, meaning that its stock price is 10% more volatile than the S&P 500. Comparatively, SI-BONE has a beta of 0.82, meaning that its stock price is 18% less volatile than the S&P 500. Do insiders and institutionals have more ownership in PRCT or SIBN? 89.5% of PROCEPT BioRobotics shares are held by institutional investors. Comparatively, 98.1% of SI-BONE shares are held by institutional investors. 17.4% of PROCEPT BioRobotics shares are held by company insiders. Comparatively, 4.0% of SI-BONE shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is PRCT or SIBN more profitable? SI-BONE has a net margin of -23.82% compared to PROCEPT BioRobotics' net margin of -50.07%. SI-BONE's return on equity of -22.51% beat PROCEPT BioRobotics' return on equity.Company Net Margins Return on Equity Return on Assets PROCEPT BioRobotics-50.07% -38.57% -26.06% SI-BONE -23.82%-22.51%-16.53% Which has higher valuation and earnings, PRCT or SIBN? SI-BONE has lower revenue, but higher earnings than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than SI-BONE, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPROCEPT BioRobotics$249.12M12.58-$105.90M-$1.70-33.32SI-BONE$176.60M4.61-$43.34M-$0.64-29.88 SummarySI-BONE beats PROCEPT BioRobotics on 10 of the 18 factors compared between the two stocks. Get SI-BONE News Delivered to You Automatically Sign up to receive the latest news and ratings for SIBN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SIBN vs. The Competition Export to ExcelMetricSI-BONESurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$814.80M$4.50B$5.37B$8.39BDividend YieldN/A43.63%5.22%4.10%P/E Ratio-20.7829.4326.7719.71Price / Sales4.6167.72393.17117.39Price / CashN/A51.0838.2534.62Price / Book4.576.236.794.50Net Income-$43.34M$68.16M$3.23B$248.18M7 Day Performance1.27%-0.19%1.53%0.20%1 Month Performance40.28%19.19%10.06%12.37%1 Year Performance36.28%21.47%16.74%7.04% SI-BONE Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SIBNSI-BONE3.5909 of 5 stars$19.12-3.0%$22.50+17.7%+36.1%$814.80M$176.60M-20.78350Insider TradePRCTPROCEPT BioRobotics2.923 of 5 stars$59.29+2.1%$90.00+51.8%-17.6%$3.28B$249.12M-30.40430Positive NewsNVSTEnvista4.1823 of 5 stars$17.68-3.2%$20.08+13.6%-9.2%$3.00B$2.50B-2.7212,700Positive NewsGap DownLIVNLivaNova3.7951 of 5 stars$43.97-1.0%$59.17+34.6%-27.9%$2.40B$1.28B104.692,900Positive NewsAnalyst UpgradeENOVEnovis3.1868 of 5 stars$35.45-1.7%$58.00+63.6%-35.7%$2.03B$2.15B-16.196,800Positive NewsNVCRNovoCure3.6348 of 5 stars$17.96+0.4%$32.83+82.8%-22.0%$2.00B$621.71M-12.831,320Positive NewsLMATLeMaitre Vascular2.5985 of 5 stars$85.96+1.4%$98.14+14.2%+3.5%$1.94B$226.26M46.97490Insider TradeSSIISS Innovations InternationalN/A$9.74-1.0%N/AN/A$1.89B$20.65M0.004CNMDCONMED4.1173 of 5 stars$60.18-0.2%$62.20+3.4%-23.3%$1.86B$1.32B14.194,100Positive NewsDividend AnnouncementWRBYWarby Parker3.1259 of 5 stars$17.59-0.7%$22.00+25.1%+18.8%$1.84B$795.09M-65.153,030Trending NewsAnalyst ForecastEYENational Vision2.7623 of 5 stars$19.22flat$17.75-7.6%+18.0%$1.52B$1.85B-96.1014,000Positive NewsAnalyst ForecastGap Down Related Companies and Tools Related Companies PROCEPT BioRobotics Competitors Envista Competitors LivaNova Competitors Enovis Competitors NovoCure Competitors LeMaitre Vascular Competitors SS Innovations International Competitors CONMED Competitors Warby Parker Competitors National Vision Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SIBN) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump + Musk = AI’s turning pointTrump may not code… but he knows how to pick winners. And according to insiders, his administration is prep...True Market Insiders | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SI-BONE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SI-BONE With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SIBN Stock Free SIBN Stock Alerts